DaVita
DVA
#2457
Rank
S$9.61 B
Marketcap
S$134.52
Share price
-5.11%
Change (1 day)
-37.39%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): S$13.10

According to DaVita's latest financial reports the company's current EPS (TTM) is S$12.80. In 2024 the company made an earnings per share (EPS) of S$14.20 an increase over its 2023 EPS that were of S$9.80.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$13.10-7.75%
2024S$14.2044.94%
2023S$9.8027.26%
2022S$7.70-35.56%
2021S$11.9544.1%
2020S$8.2919.7%
2019S$6.93540.48%
2018S$1.08-76.07%
2017S$4.52-19.31%
2016S$5.60242.52%
2015S$1.64-62.87%
2014S$4.4013.43%
2013S$3.888.45%
2012S$3.58

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Tenet Healthcare
THC
S$18.93 47.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
S$2.44-80.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Universal Health Services
UHS
S$27.49 114.79%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
S$13.20 3.12%๐Ÿ‡บ๐Ÿ‡ธ USA